Literature DB >> 3756818

An excess of uterine sarcomas after pelvic irradiation.

R F Meredith, D R Eisert, Z Kaka, S E Hodgson, G A Johnston, J G Boutselis.   

Abstract

The Ohio State University Registry recorded 1208 uterine corpus malignancies between 1940 and 1983. Thirty cases occurred in women with a history of pelvic irradiation. Eight patients had previously been irradiated for pelvic malignancy, four of whom presented with advanced stage sarcomas and died of their disease within 14 months. This represents an increase over the expected sarcoma prevalence which is less than 5%. In contrast, the majority of women (20 of 22) previously irradiated for benign conditions were diagnosed with endometrial adenocarcinoma. In 18, the adenocarcinoma was diagnosed as Stage I, and the prognosis was only slightly less favorable than for nonirradiated women. No significant effect of age at the time of irradiation was apparent. This study of women with a history of pelvic irradiation who later developed uterine cancer demonstrates a tendency for patients previously irradiated for pelvic malignancy to present with advanced stage, extremely aggressive uterine tumors compared to those previously irradiated for benign conditions.

Entities:  

Mesh:

Year:  1986        PMID: 3756818     DOI: 10.1002/1097-0142(19861101)58:9<2003::aid-cncr2820580908>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Endometrial stromal sarcoma of the sigmoid colon: a case report and literature review.

Authors:  Takuya Tajiri; Kosuke Mima; Kosuke Kanemitsu; Toru Takematsu; Keisuke Kosumi; Mitsuhiro Inoue; Takao Mizumoto; Tatsuo Kubota; Reiji Muto; Toshihiko Murayama; Nobutomo Miyanari; Hideo Baba
Journal:  Int Cancer Conf J       Date:  2021-07-14

Review 2.  Uterine/female genital sarcomas.

Authors:  M L Hensley
Journal:  Curr Treat Options Oncol       Date:  2000-06

3.  Uterine carcinosarcomas (malignant mixed müllerian tumours): a review with special emphasis on the controversies in management.

Authors:  Rani Kanthan; Jenna-Lynn Senger
Journal:  Obstet Gynecol Int       Date:  2011-10-05

4.  Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes.

Authors:  Siân Jones; Nicolas Stransky; Christine L McCord; Ethan Cerami; James Lagowski; Devon Kelly; Samuel V Angiuoli; Mark Sausen; Lisa Kann; Manish Shukla; Rosemary Makar; Laura D Wood; Luis A Diaz; Christoph Lengauer; Victor E Velculescu
Journal:  Nat Commun       Date:  2014-09-19       Impact factor: 14.919

5.  Uterine sarcoma. Clinico-pathological characteristics and outcome.

Authors:  Hesham K Sait; Nisreen M Anfinan; Mohamed E El Sayed; Shadi S Alkhayyat; Ahmed T Ghanem; Reem M Abayazid; Khalid H Sait
Journal:  Saudi Med J       Date:  2014-10       Impact factor: 1.484

6.  Trends of uterine carcinosarcoma in the United States.

Authors:  Koji Matsuo; Malcolm S Ross; Hiroko Machida; Erin A Blake; Lynda D Roman
Journal:  J Gynecol Oncol       Date:  2018-01-05       Impact factor: 4.401

7.  Outcomes of carcinosarcoma in a tertiary care institution in India.

Authors:  Anne George Cherian; Anitha Thomas; Ajit Sebastian; Tunny Sebastian; Vinotha Thomas; Rachel G Chandy; Abraham Peedicayil
Journal:  South Asian J Cancer       Date:  2018 Jan-Mar

Review 8.  Update on Endometrial Stromal Tumours of the Uterus.

Authors:  Iolia Akaev; Chit Cheng Yeoh; Siavash Rahimi
Journal:  Diagnostics (Basel)       Date:  2021-03-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.